NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 3 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding NovaBridge Biosciences changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 47 | 0 |
| Shares | 18.7M | 162.6K | 15.3M | −3.28M (−17.7%) |
| Value | $55.9M | $486.1K | $20.1M | −$35.3M (−63.7%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held NovaBridge Biosciences at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 554,746 | $732.3K | 0.00% |
| Acadian Asset Management LLC | 128,299 | $168.0K | 0.00% |
| Jane Street Group, LLC | 127,241 | $168.0K | 0.00% |
| Susquehanna International Group, LLP | 50,169 | $66.2K | 0.00% |
| Canada Pension Plan Investment Board | 46,042 | $60.8K | 0.00% |
| Prelude Capital Management, LLC | 39,471 | $52.1K | 0.00% |
| Centiva Capital, LP | 25,923 | $34.2K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 23,639 | $31.2K | 0.00% |
| Pinebridge Investments, L.P. | 23,570 | $31.1K | 0.00% |
| Virtu Financial LLC | 14,588 | $19.0K | 0.00% |
| Squarepoint Ops LLC | 12,561 | $16.6K | 0.00% |
| Headlands Technologies LLC | 7,394 | $9.76K | 0.00% |
Sold out (12)
Institutions that held NovaBridge Biosciences at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Vanguard Group Inc | 2,115,277 | $6.32M |
| Handelsbanken Fonder AB | 120,502 | $360.0K |
| California Public Employees Retirement System | 106,938 | $319.7K |
| Nuveen Asset Management, LLC | 33,500 | $100.2K |
| Mackenzie Financial Corp | 31,837 | $93.6K |
| Caxton Associates LP | 25,132 | $75.1K |
| Vident Investment Advisory, LLC | 10,693 | $32.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,284 | $6.83K |
| Fisher Asset Management, LLC | 861 | $2.57K |
| Citadel Advisors LLC | 485 | $1.45K |
| Advisor Group Holdings, Inc. | 3 | $8 |
| Ronald Blue Trust, Inc. | 39 | $0 |
Not filed for Q3 2023 yet (1)
Institutions that held NovaBridge Biosciences at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 162,580 | $486.1K |